Philippe Cotelle

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 5

Top Topics

Benign Prostatic Hyperplasia

Gene Expression

Breast Cancer Cells

Cell Proliferation

Top Venues

Journal of medicinal chemistry

Expert opinion on therapeutic patents

This page only lists publications with an associated author ORCID identifier.

Publications

Benjamin Zagiel, Patricia Melnyk, Philippe Cotelle
Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present). Expert opinion on therapeutic patents 32 (8) (2022)
Maxime Liberelle, Florine Toulotte, Nicolas Renault, Muriel Gelin, Frédéric Allemand, Patricia Melnyk, Jean-François Guichou, Philippe Cotelle
Toward the Design of Ligands Selective for the C-Terminal Domain of TEADs. Journal of medicinal chemistry 65 (8) (2022)
Floriane Gibault, Manon Sturbaut, Mathilde Coevoet, Martine Pugnière, Ashley Burtscher, Frédéric Allemand, Patricia Melnyk, Wanjin Hong, Brian P Rubin, Ajaybabu V Pobbati, Jean-François Guichou, Philippe Cotelle, Fabrice Bailly
Design, Synthesis and Evaluation of a Series of 1,5-Diaryl-1,2,3-triazole-4-carbohydrazones as Inhibitors of the YAP-TAZ/TEAD Complex. ChemMedChem 16 (18) (2021)
Floriane Gibault, Fabrice Bailly, Matthieu Corvaisier, Mathilde Coevoet, Guillemette Huet, Patricia Melnyk, Philippe Cotelle
Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway. ChemMedChem 12 (12) (2017)
Floriane Gibault, Manon Sturbaut, Fabrice Bailly, Patricia Melnyk, Philippe Cotelle
Targeting Transcriptional Enhanced Associate Domains (TEADs). Journal of medicinal chemistry 61 (12) (2017)